Pelham Fire Rescue Website
|
Pelham Fire Rescue Website |
|
|
|
 |
|
 |
 |
 |
 | |||||||||||||||||||||||||||||
            |
Public Information:
May 17, 2008: NEWS from CPSCU.S. Consumer Product Safety Commission
Maple Chase Co. Recalls Carbon Monoxide and Carbon Monoxide/Smoke Combo Alarms Due to Alarm MalfunctionWASHINGTON, D.C. - The U.S. Consumer Product Safety Commission, in cooperation with the firm named below, today announced a voluntary recall of the following consumer product. Consumers should stop using recalled products immediately unless otherwise instructed. Name of Product: FireX Branded 10000 Series Carbon Monoxide (CO) Alarms and 12000 Series CO/Smoke Combo Alarms Units: About 280,000 Manufacturer: Maple Chase Company, of Plain City, Ohio Hazard: The recalled alarms can sound a “double chirp”/fault alarm in the presence of CO, prior to going into full alarm. Upon hearing a double chirp, the Owner’s Manual instructions recommend a consumer take the alarm out of service, which could expose consumers to hazardous levels of CO and suffer injury or death. Incidents/Injuries: None reported. Description: The recall includes FireX branded 10000 and 12000 series alarms with item numbers: 10000, 12000, 12000C, 12000-6, 12200, 12220, 12400, 12400C manufactured between June 1, 2007 and February 1, 2008. The date code appears on the back of the unit with a four digit year, three digit month followed by the day (ex: 2007JUN1 for June 1, 2007). Units with a manufacture date code prior to June 1, 2007 are not included in this recall. Sold: Commercial electrical distributors and electrical contractors and builders for installation into new home construction. A limited number of units were sold at Menard’s nationwide from June 2007 through February 2008 for about $20 (10000 series) and $30 (12000 series). Manufactured in: Mexico Remedy: Consumers should contact Maple Chase immediately to receive a free comparable replacement alarm and make arrangements to return their recalled alarms. Consumers should not take the alarms out of service until they receive the replacement alarm. Consumer Contact: For more information, contact Maple Chase toll-free at (888) 879-3906 between 8 a.m. and 6 p.m. CT Monday through Friday or go to the firm’s Web site at www.firexsafety.com
--- Send the link for this page to a friend! The U.S. Consumer Product Safety Commission is charged with protecting the public from unreasonable risks of serious injury or death from more than 15,000 types of consumer products under the agency's jurisdiction. Deaths, injuries and property damage from consumer product incidents cost the nation more than $800 billion annually. The CPSC is committed to protecting consumers and families from products that pose a fire, electrical, chemical, or mechanical hazard. The CPSC's work to ensure the safety of consumer products - such as toys, cribs, power tools, cigarette lighters, and household chemicals - contributed significantly to the decline in the rate of deaths and injuries associated with consumer products over the past 30 years. To report a dangerous product or a product-related injury, call CPSC's hotline at (800) 638-2772 or CPSC's teletypewriter at (800) 638-8270, or visit CPSC's web site at www.cpsc.gov/talk.html. To join a CPSC email subscription list, please go to https://www.cpsc.gov/cpsclist.aspx. Consumers can obtain this release and recall information at CPSC's Web site at www.cpsc.gov.
April 17, 2008:
2007 New Hampshire Association of Fire Chiefs Report
April 16, 2008: This is an official CDC Health Advisory
Distributed via Health Alert Network April 14, 2008, 18:50 EDT (06:50 PM EDT)CDCHAN-002 74-08-04-14-ADV-NCDC Alert on Adverse Effects Associated with Consuming “Total Body Formula” and “Total Body Mega Formula” The Centers for Disease Control and Prevention is working collaboratively with state health departments, the American Association of Poison Control Centers, and the U.S. Food and Drug Administration (FDA) on reports of adverse health effects following consumption of the dietary supplement “Total Body Formula,” and “Total Body Mega Formula” manufactured in the USA exclusively for Total Body Essential Nutrition, Inc. This dietary supplement has been found by FDA to contain hazardous levels of selenium (up to 200 times the label value) and chromium (up to 17 times the label value). An FDA press release on April 9, 2008 detailed information regarding the level of selenium in the product ( http://www.fda.gov/bbs/topics/NEWS/2008/NEW01818.html). FDA is advising consumers to stop using “Total Body Formula” in flavors Tropical Orange and Peach Nectar and “Total Body Mega Formula” in the Orange/Tangerine flavor and discard them by placing them in a trash receptacle outside of the home. “Total Body Formula” products are sold in eight-ounce and 32-ounce plastic bottles. “Total Body Mega Formula” is sold in 32-ounce plastic bottles. Products with the following lot numbers should be discarded: Total Body Tropical Orange with lot numbers 4016801, 4024801 and 4031801; Total Body Peach Nectar with lot numbers 4016802 and 4031802; and Total Body Mega Orange/Tangerine with lot number 4031803.As of April 11, 2008, 91 adverse reactions have been reported from Florida, Georgia, Kentucky, Pennsylvania, Tennessee, and Virginia health departments. The American Association of Poison Control Centers and the FDA report additional exposures in other states. Total Body Essential Nutrition, Inc reportedly distributed this product to 16 states (Alabama, California, Florida, Georgia, Kentucky, Louisiana, Michigan, Missouri, New Jersey, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, and Virginia), and also sells its products over the Internet. Clinical description of selenium toxicity Excessive intake of selenium is known to cause the following symptoms: significant hair loss, muscle cramps, diarrhea, joint pain, fatigue, loss of finger nails and blistering skin. Clinical description of chromium toxicity Excessive intake of chromium may result in the following symptoms: renal failure, elevated hepatic enzymes, thrombocytopenia, hemolysis, changes in thought processes, gastrointestinal disorders, chest pain, erythema/flushing/rash, dizziness, headache, agitation, and rhabdomyolysis. Case definition Individuals presenting with two or more of the following symptoms that occurred within two weeks of ingesting a dietary supplement manufactured in the USA exclusively for Total Body Essential Nutrition, Inc: hair loss, muscle or joint pains, fingernail discoloration or changes, headache, foul breath, weakness, gastrointestinal symptoms (such as nausea, vomiting, diarrhea or abdominal pain), rash, oliguria/anuria or abnormal renal function tests, jaundice or abnormal liver function tests, anemia or hematological changes. CDC requests that consumers and clinicians who encounter patients with symptoms consistent with selenium and/or chromium poisoning report these cases to their local poison control center (PCC) at 1-800-222-1222. Medical personnel are available at PCCs to provide specific medical management advice and will make appropriate referral to state and local health authorities. Health care professionals and consumers are also encouraged to report adverse events to the FDA's MedWatch program at 800-FDA-1088 or online at www.fda.gov/medwatch/how.htm.__________________________________________________________________________________________________________________ Categories of Health Alert messages: Health Alert conveys the highest level of importance; warrants immediate action or attention. Health Advisory provides important information for a specific incident or situation; may not require immediate action. Health Update provides updated information regarding an incident or situation; unlikely to require immediate action.
##This Message was distributed to State and Local Health Officers, Epidemiologists, State Laboratory Directors, PHEP Coordinators, HAN Coordinators and Public Information Officers as well as Public Health Associations and Clinician organizations##
March 19, 2008: Flood Lines (opens in PDF)
March 7, 2008: Please click on the link below for information on the upcoming public meetings regarding the Independent Evaluation of Recent Flooding in New Hampshire .
http://www.des.state.nh.us/press/archive/2008/press03062008.htm
March 7, 2008:
Concord Fire's Snow Load Report (opens in Microsoft Word)
March 7, 2008:
March 2008 NNEPC E-Updates (click here opens in PDF)
March 7, 2008: "Anoutdoor enthusiast's guide to wildlife-related diseases" discusses
avian February 28, 2008 The Pelham Fire department is aware of the rise of influenza and wishes to remind everyone to take appropriate precautions such as frequent hand washing, covering your mouth and nose when sneezing and staying home if you are ill. Please check on those who are susceptible such as the elderly, children, and those who have current health issues. Please visit www.cdc.gov for updated information.
February 22, 2008 Health Advisory (opens in Microsoft Word
February 21, 2008 NEWS from CPSC
February 21, 2008
Yellow Fever Vaccination Locations (opens in PDF)
Travel Centers Aug 07.pdf(34KB)
February 1, 2008 Pelham Fire Department
Dear Citizens of Pelham, Date: 02-05-2008
The Firefighters of the Town of Pelham would like to invite you to our Open House at the fire station at 65 Old Bridge Street North, on Saturday, March 8th from 10am to 3pm. Take the opportunity to meet the Fire Chief and your local firefighters and take a tour of the fire house. Also, there will be coffee, juice, popcorn and hot dogs provided by the Pelham Firefighters Auxiliary. We always appreciate the opportunity to answer your questions and concerns; we feel it is important to have a dialog with our residents and an understanding of your needs. This year we have the new fire station on the ballot and we would like to, at the very least, give you the correct information so you can make an informed decision at the next town vote. For more information you may contact us at 603-635-2703.
Town of Pelham Firefighters
January 28, 2008 Release from Homeland Security "Protecting Mass
Transit Systems, Part II" -
click here to
view
January 11, 2008
NH Department of Health and Human Services 129 Pleasant Street – Hugh Gallen State Office Park Concord, NH 03301
PRESS RELEASE CONTACT For Immediate Release Public Information Office January 9, 2008 603-271-4051
DHHS Issues Reminder to Residents: Take Simple Steps to Stop the Spread of Norovirus This Season
Concord, NH – The winter season is typically the time of year when there’s an increase in the incidence of noroviruses, so the New Hampshire Department of Health and Human Services (DHHS) is offering tips to help guard against the spread of this illness.
Noroviruses are a group of viruses that cause gastrointestinal illness or what many people refer to as “the stomach flu.” Noroviruses are highly contagious and can be responsible for large outbreaks in communal settings such as long-term care facilities, schools, and in daycares.
“New Hampshire residents can play an important role in helping to stop the spread of norovirus and other illnesses,” said State Epidemiologist Dr. Jose Montero, “but it requires that all of us be vigilant in our personal hygiene habits.”
Noroviruses can be transmitted a number of ways, including through person-to-person contact, consumption of contaminated food and water, airborne droplets of vomit, and contact with contaminted surfaces, such as doorknobs and faucets. Symptoms of the illness include vomiting, diarrhea, abdominal cramps, nausea, fever, and headache.
There is no treatment for Norovirus, but symptoms typically resolve within 48 hours. DHHS’s Division of Public Health Services (DPHS) recommends following these common sense steps to aid in prevention:
· Wash hands with soap and warm water after using the bathroom and changing diapers · Wash hands with soap and warm water before preparing or eating food · Cook shellfish thoroughly before eating · Wash raw vegetables before eating · Food service workers with symptoms of norovirus should not prepare or touch food · Health care workers with norovirus symptoms should stay home from work
(more)
“Following these simple measures will help more New Hampshire residents stay healthy during this winter season,” Montero said. DPHS’s Communicable Disease Control and Surveillance Section will continue monitoring norovirus activity in New Hampshire. More information about noroviruses is available on the DHHS website at www.dhhs.nh.gov and on the Centers for Disease Control and Prevention website at www.cdc.gov.
###
December 31, 2007
The following updates were made to CDC information and guidance from Dec. 17-31, 2007. If you have any questions on these or other clinical issues, please write to us at coca@cdc.gov. Today's topics Include:
Emerging Infectious Disease (EID) Journal
COCA Conference Call AudioAudio for Disaster Surveillance Call posted on Website
- Dec. 19 Please know that if you were not able to participate in the live COCA Conference Call on Disaster Surveillance, you can still get Continuing Education credit! Simply download the PowerPoint, follow along with the audio file and then complete the on-line evaluation. The instructions for obtaining credit can be found at the end of the PowerPoint slides. Please email coca@cdc.gov with any questions. Interim Recommendations for Hib Conjugate VaccinesInterim Recommendations for the Use of Haemophilus influenzae Type b (Hib)
Conjugate Vaccines Related to the Recall of Certain Lots of Hib-Containing
Vaccines (PedvaxHIB® and Comvax®) - MMWR - Dec. 21 Avian InfluenzaAvian Influenza - situation in Egypt - WHO
update - Dec. 28 Avian Influenza - situation in Viet Nam - WHO
update - Dec. 28 Avian Influenza - situation in Pakistan - WHO
update - Dec. 27 Cumulative Number of Confirmed Human Cases of Avian Influenza A/H5N1-
WHO - Dec. 28 H5N1 avian influenza: timeline of major events -
PDF file - WHO - Dec. 17 Seasonal InfluenzaWeekly Report: Influenza Summary Update - Dec.
28 Travelers' HealthNew vaccination requirements for travelers to Bolivia
- CDC - Dec. 21 Updated case numbers: Ebola Outbreak in the District of Bundibugyo,
Uganda - CDC - Dec. 20
The CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services. Links to non-Federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the Federal Government, and none should be inferred. The CDC is not responsible for the content of the individual organizations. Please send us your feedback or comments: http://www.cdc.gov/flu/coca/feedback.htm. Our Clinician Communication Team is committed to excellence in
reporting our weekly updates. Please e-mail
coca@cdc.gov
should you note any written errors or discrepancies.
12/29/2007 This is an official CDC Health Advisory
Distributed via Health Alert Network December 29, 2007, 19 :35 EST (07:35 PM EST)CDCHAN-00267-07-12-29-ADV-N Investigation of International Traveler with Multidrug-Resistant Tuberculosis (MDR TB)
The Centers for Disease Control and Prevention (CDC) is working with international, state, and local health officials and other partners on an investigation involving an international traveler to the U.S. who had recently been diagnosed with multidrug-resistant tuberculosis (MDR TB). CDC was informed in mid-December 2007 by a local health authority that a patient who had been diagnosed in India with MDR TB traveled from New Delhi, India to Chicago, Illinois on December 13, 2007 on American Airlines Flight # 293 and then on a shorter flight within the United States. Shortly after final arrival, the patient sought treatment for hemoptysis, fever, and chest pain at a hospital. These and other findings indicated a potential for transmission of drug-resistant TB infection to others. The patient has been hospitalized in airborne isolation and is receiving treatment for TB.Shortly after being notified about the patient and her travels, officials of CDC’s Division of Global Migration and Quarantine contacted American Airlines and U.S. Customs and Border Protection to obtain the information needed to contact passengers who may have been exposed to the traveler with tuberculosis. CDC is collaborating with U.S. state and local health departments, the Indian Ministry of Family Welfare, American Airlines, and the Department of Homeland Security’s Customs and Border Protection to ensure notification and follow-up of passengers and crew who may have been exposed to MDR TB. In accordance with the World Health Organization (WHO) TB and Airline Travel Guidelines, CDC is ensuring appropriate follow-up and care for persons who may have been exposed to TB on an aircraft. This includes recommending the evaluation and testing of passengers and crew with closest contact to the patient on board American Airlines Flight #293 departing from New Delhi, India on December 13, 2007 and arriving in Chicago, Illinois on December 13, 2007. This includes 44 passengers. These were the passengers seated in the same row as the index patient (row 35), and those seated in the two rows ahead (rows 33 and 34) and the two rows behind (rows 36 and 37), as well as the crew members working in the same cabin. These persons should receive an initial evaluation and testing for TB infection, with follow-up 8 to 10 weeks after the December 13 flight for re-evaluation. CDC recommends testing of these passengers and crew on only the international flight from New Delhi to Chicago because this flight was longer than the 8 hour duration criteria specified by WHO for passenger testing for exposure to tuberculosis. WHO and CDC do not recommend notification or medical evaluation of passengers on briefer flights because the risk of transmission is minimal. WHO guidelines can be found at http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.363_eng.pdfCDC issued an Epi-X notification on December 28, 2007 to health officials in 17 states based on locating information provided by 42 of the 44 potentially exposed passengers. (Locating information was not available on two passengers). These states include California, Colorado, Florida, Georgia, Illinois, Indiana, Kansas, Michigan, Minnesota, Missouri, New Jersey, North Carolina, Ohio, Tennessee, Texas, Vermont, and Virginia. These states should inform CDC’s Division of Global Migration and Quarantine’s duty officer if they are unable to contact any of the passengers with destinations in their states. The duty officer can be reached by calling CDC’s Director’s Emergency Operation Center (DEOC) at (770) 488-7100. Drug-susceptible (regular) TB and MDR TB are thought to be spread the same way. The risk of acquiring any type of TB appears to depend on several factors, such as extent of disease in the source patient, duration of exposure, and ventilation. TB bacilli become aerosolized when a person with TB disease of the lungs or throat coughs, sneezes, speaks, or sings. These bacilli can float in the air for several hours, depending on the environment. Persons who breathe air containing these TB bacilli can become infected. Transmission has been documented in association with patients who have TB lung disease, and bacteria seen or cultured in sputum. Persons who become infected usually have been exposed for several hours (or days) in poorly ventilated or crowded environments. An important way to prevent the spread and transmission is by limiting an infectious person’s contact with other people. Thus, people who have suspected or confirmed TB or MDR TB that is potentially infectious should be placed on treatment and kept isolated until they are no longer infectious. State and local health departments who want additional information may contact CDC’s Division of Global Migration and Quarantine’s duty officer through the CDC Director’s Emergency Operation Center (DEOC) at (770) 488-7100. Persons who believe they may have been exposed to TB or MDR TB, or their clinicians, can call 1-800 CDC INFO for further information. Where to go for information about: Tuberculosis: http://www.cdc.gov/tb/default.htmMDR TB: http://www.cdc.gov/tb/pubs/tbfactsheets/mdrtb.htm http://www.cdc.gov/tb/pubs/tbfactsheets/drugresistanttreatment.htm
Infection control: http://www.cdc.gov/tb/pubs/tbfactsheets/ichcs.htm and http://www.cdc.gov/tb/pubs/tbfactsheets/rphcs.htmTuberculosis and Air Travel: http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.363_eng.pdf____________________________________________________________________________________ Categories of Health Alert messages: Health Alert conveys the highest level of importance; warrants immediate action or attention. Health Advisory provides important information for a specific incident or situation; may not require immediate action. Health Update provides updated information regarding an incident or situation; unlikely to require immediate action. ## This Message was distributed to State and Local Health Officers, Epidemiologists, State Laboratory Directors, PHEP Coordinators, HAN Coordinators and Public Information Officers as well as Public Health Associations and Clinician organizations ##
The CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services. Links to non-Federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the Federal Government, and none should be inferred. The CDC is not responsible for the content of the individual organizations. Please send us your feedback or comments: http://www.cdc.gov/flu/coca/feedback.htm. Our Clinician Communication Team is committed to excellence in
reporting our weekly updates. Please e-mail
coca@cdc.gov
should you note any written errors or discrepancies.
|
| ||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||
 |
 |
 |
 | |||||||||||||||||||||||||||||
 |
 |
 |
